Skip to main content

Table 2 Results of the n-way ANOVA test on GP% (3%, 2 mm) with respect to all the collected planning parameters in terms of p-values

From: Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report

 

(3%L, 2 mm)

(3%G, 2 mm)

Site

0.002

0.063

MF

0.294

0.199

TTDF

0.007

0.373

mean-LOT

0.642

0.437

max-LOT

0.804

0.859

Pitch

0.884

0.659

Gantry period

0.820

0.841

Couch speed

0.189

0.055

  1. Underlined values mark significant tests
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us